NCT Number: NCT00219050
A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension
To compare the safety and efficacy of an aliskiren-based regimen to a lisinopril-based regimen in the treatment of severe hypertension
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Investigative Site, Berlin, Germany
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with essential severe hypertension Exclusion Criteria
- History or evidence of a secondary form of hypertension
- History of hypertensive encephalopathy or cerebrovascular accident.
- Diabetic patients requiring insulin Other protocol-defined inclusion/exclusion criteria also apply
Treatment and study plan
Primary outcomes
-
Evaluate safety through adverse events and laboratory abnormalities after 8 weeks
Secondary outcomes
-
Change from baseline in diastolic blood pressure after 8 weeks
-
Change from baseline in systolic blood pressure after 8 weeks
-
Change from baseline in standing systolic blood and diastolic pressure after 8 weeks
-
Diastolic blood pressure is less than 90 mmHg or reduction of 10 mmHg or greater from baseline after 8 weeks
Sponsors and collaborators
Lead sponsor
Novartis
Industry
Registry information
Official study title
An Eight-week, Randomized, Double-blind, Multi-center, Active-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of an Aliskiren-based Regimen Compared to a Lisinopril-based Regimen in Patients With Uncomplicated Severe Hypertension
Important dates
- Study start
- 2005
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Sep 22, 2005
- Registry last updated
- Feb 25, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Improving Hypertension Medication Adherence for Older Adults
NCT05610059
Aging, Behavior
Tucson, Arizona, United States
View Trial DetailsSPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
NCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsEffects of a 10-Week Zumba Program in Adults With Hypertension
NCT07735468
Behavior, Cardiovascular Diseases
Osuna, Sevilla, Spain
View Trial DetailsGenetics of Type 2 Diabetes in West Africans
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial Details